Company intelligence / Profile preview

DNA Medical Communications

Knutsford, United Kingdom

Ownership: Private
Employees: ~50
Development stage: Other

Overview

DNA Medical Communications is a specialized medical communications agency that provides scientific strategy, medical education, and publication planning services to the pharmaceutical and biotechnology industries. The company focuses on translating complex science into compelling narratives to support product launches and lifecycle management across various therapeutic areas. In 2020, it was acquired by Fishawack Health (now Avalere Health), integrating its expertise into a broader global healthcare commercialization platform. The agency is recognized for its high-science approach and its ability to engage healthcare professionals through evidence-based communication strategies.

Industry: Consulting

Beyond the preview

Go deeper on DNA Medical Communications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA Medical Communications.

Explore the full profile